WallStreetZenWallStreetZen

How to Buy Maxcyte Stock

Maxcyte Inc

MaxCyte, Inc. , a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies.

Maxcyte stock last closed at $3.96, up 0.25% from the previous day, and has decreased 20.64% in one year. It has underperformed other stocks in the Medical Devices industry by 0.02 percentage points. Maxcyte stock is currently +61.63% from its 52-week low of $2.45, and -28.58% from its 52-week high of $5.55.

There are currently 104.13M MXCT shares outstanding. The market cap of MXCT is $412.35M. In the last 24 hours, 748,618 MXCT shares were traded.

How to Buy Maxcyte Stock

Wondering how to invest in Maxcyte stock? Here's how.
  1. Decide where to buy Maxcyte stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Maxcyte stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Choose your payment method and add your information.
  4. Evaluate Maxcyte stock: The Maxcyte ticker symbol is MXCT. Is Maxcyte stock a good investment? Should you buy shares of MXCT? How do MXCT's underlying business fundamentals look? Do top analysts think Maxcyte is a good buy? Why has MXCT's stock price moved recently? (Hint: Our stock research website can help you decide if MXCT is a good stock to buy).
  5. Execute your MXCT buy order: Decide if you will purchase MXCT shares at the current market price or use a limit order to purchase MXCT shares at a given price.
  6. Track your MXCT investment: Create a watchlist to important updates regarding your new investment in Maxcyte shares.

Step 1: Decide where to buy Maxcyte stock

You will need a brokerage account in order to access the NASDAQ market and buy MXCT shares.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen the best brokerage, it's time to fill out some personal details so you are able to invest in MXCT today.

How to Open a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create your new brokerage account.
  1. Send your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have opened your account on the best stock market app for beginners, you can securely and quickly fund your account:

Check out the video below if you need help transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Maxcyte stock

After you have decided on the best place to buy Maxcyte stock, it's crucial to evaluate their stock prior to buying, so you truly understand the risk and upside.

Maxcyte Metrics

MXCT Price
$3.96
1w %
2.06%
1y %
-20.64%
5y %
N/A
P/E
-10.7x
P/B
1.78x
P/S
9.9x
PEG
N/A
Revenue
$41.29M
Earnings
-$37.92M
Fore. Rev. Growth
-17.29%
Fore. Earn. Growth
N/A
Market Cap
$412.35M
Next Earnings
May 7, 2024
Next Dividend
N/A

Maxcyte Fundamentals

WallStreetZen was designed to help average investors do better fundamental analysis in less time.

You can view all of the due diligence checks on MXCT's stock page.

Is MXCT stock undervalued or overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MXCT's fair value.

Using relative valuations methods:

  • MXCT could be undervalued based on its P/B ratio of 1.78x, relative to Medical Devices industry P/B ratio of 3.65x

You can do more valuation analysis on MXCT's stock here.

MXCT Financial Health Overview

Pros:

  • MXCT has cash burn of 25377000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the MXCT balance sheet.
  • MXCT has $168.29M in cash and short term investments. This is sufficient to cover its annual cash burn of $25.38M.
  • MXCT has a low debt to equity ratio of 0.16.
  • There are more short-term assets than short-term liabilities on the MXCT balance sheet.

Cons:

  • MXCT profit margin has gone down from -53.3% to -91.8% in the past year.

Is it a good time to buy Maxcyte stock, according to analysts?

Out of 3 Equities analysts who monitor MXCT, the consensus analyst rating on MXCT is a Strong Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are saying on the Maxcyte stock forecast page.

MXCT Technical Indicators

SMA10
1.05
SMA20
1.1
SMA50
1.14
SMA100
1.23
SMA200
1.17
MACD
-0.05
MACD Signal
-0.04
MACD Histogram
-0.01
RSI
39.88
Stochastic %K
36.4
Stochastic %D
33.38
StochRSI %K
43.67
StochRSI %D
36.18

How are MXCT Revenues/Earnings doing?

Last year, MXCT revenue was $41.29M. Over the last four year, MXCT's revenue has gone up by 17.55% per year. This was faster than the Medical Devices industry average of 13.34%.

You can analyze MXCT's earnings and revenue performance here.

Who is buying/selling MXCT?

Over the past year, executives and large shareholders at MXCT have bought as many shares as they have sold.

John Joseph Johnston, Director of MXCT, was the latest MXCT insider to sell. They sold $22,025.00 worth of MXCT shares on Mar 26, 2024.

Learn more about who owns MXCT shares here.

Does MXCT provide a stable income stream?

No, Maxcyte doesn't provide an income stream by paying out dividends.

What do other investors have to say about MXCT?

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Execute your MXCT buy order

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a given price limit, use a limit order.

Press the Open button and eToro will place the order.

If you require more help with buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Track your MXCT investment

Now that you own some MXCT stock, you'll want to stay up-to-date on your new stock purchase.

Make a watchlist to get the latest updates about your MXCT stock.

MXCT Feed

How to Buy Stock in Maxcyte

To summarize, here are the 6 steps you need to take to buy Maxcyte stock right now:

  1. Decide where to buy Maxcyte stock
  2. Create a brokerage account
  3. Deposit funds into your brokerage account
  4. Evaluate Maxcyte stock
  5. Execute your MXCT buy order
  6. Track your MXCT investment

If you require a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your investment in Maxcyte, click below.

NASDAQ: MXCT
$3.96+0.01 (+0.25%)
Updated Apr 22, 2024
Open eToro Account
NASDAQ: MXCT
$3.96+0.01 (+0.25%)
Updated Apr 22, 2024
Open eToro Account

FAQ

How much does it cost to buy one Maxcyte share?

As of Apr 22, 2024, it costs $3.96 to buy one share of Maxcyte stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.253 shares of MXCT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Maxcyte stock?

According to 3 Wall Street analysts who monitor Maxcyte, their consensus recommendation is to buy Maxcyte stock.

What is the best way to buy Maxcyte stock?

One way to place an order for Maxcyte stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.